ARCHIVES

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

This article is from The Cancer Letter archive.

Vol. 15 No. 48 | December 15, 1989

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

Lederle Scientists Report Powerful New Anticancer Agent

July 31, 1987

Grassley Seeks Data On Sponsored Travel By NCI Scientists

October 29, 2010

Memorial Sloan Kettering Seizes Top Cancer Hospital Prize From MD Anderson in U.S. News & World Report Ranking

July 15, 2014

Momentum Continues For Private Development Of Free Standing Cancer Centers

July 19, 1985

Center Directors Solidly opposed To Core grant changes, Ask Upton, NCAB To Find Other Solutions

November 11, 1977